Obesity trials in Greece

In Greece 36 Also abroad 1939

36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Exercise Training and Vitamin D Metabolism
Where
Trikala
Age
35 years to 50 years
People
30
Run by
University of Thessaly
See details and how to joinNCT07300332
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Athens, Heraklion, Thessaloniki
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Athens, Heraklion, Thessaloniki
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
Where
Athens, Larissa, Maroussi, Paleo Faliro, Thessaloniki
Age
18 years and over
People
932 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Alexandroupoli, Athens, Chios, Larissa, Marousi, Marousi, Athens, Nea Ionia, Piraeus, Thessaloniki
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Alexandroupoli, Athens, Chaïdári, Chios, Larissa, Maroussi, Nea Ionia, Piraeus, Thessaloniki, Voula
Age
18 years and over
People
2,787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Where
Athens, Larissa, Maroussi, Paleo Faliro, Thessaloniki
Age
18 years and over
People
549 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00
Phase 3Not yet taking people in Greece
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Athens, Chaïdári, Chania, Chios, Cholargos, Efkarpia, Eleusina, Ioannina, Kifissia, Larissa, Maroussi, Patras, Peristeri, Thessaloniki
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Athens, Lamia, Maroussi, Paleo Faliro, Peristeri, Thessaloniki
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Where
Athens, Larissa, Marousi, Palaió Fáliro, Pylaia, Thessaloniki
Age
18 years and over
People
1,560 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Where
Athens, Larissa, Marousi, Palaió Fáliro, Pylaia, Thessaloniki
Age
18 years and over
People
3,003 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743463
Phase 3Taking people
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Where
Kalamata, Maroussi, Peristeri, Thessaloniki
Age
18 years and over
People
450 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07770841 · EU 2025-524626-18-00
Phase 3Taking people
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Where
Athens, Iraklio (Kritis), Peristeri, Thessaloniki
Age
18 years and over
People
285 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07745504 · EU 2025-524249-29-00
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Athens, Chaïdári, Chalkida, Chios, Cholargos, Iraklio (Kritis), Kalamata, Larissa, Maroussi, Melissia, Nea Ionia, Peristeri, Thessaloniki, Voula
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
Phase 3Taking people
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Where
Athens, Chaïdári, Maroussi, Thessaloniki
Age
18 years and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00
No phaseNot yet taking people in Greece
Chrono-Fasting in Overweight and Obese Adolescents
Where
Larissa
Age
12 years to 18 years
People
120
Run by
University of Thessaly
See details and how to joinNCT07759414
No phaseTaking people
25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases
Where
Athens, Nea Liosia
Age
20 years to 85 years
People
120
Run by
Dionyssiotis, Yannis, M.D.
See details and how to joinNCT06791044
No phaseTaking people
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
Where
Athens
Age
18 years and over
People
220
Run by
National and Kapodistrian University of Athens
See details and how to joinNCT07653412
Phase 3Taking people
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Where
Athens, Chaïdári, Maroussi, Thessaloniki
Age
18 years and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07481630 · EU 2024-520444-42-00
No phaseNot yet taking people in Greece
Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers.
Where
Athens
Age
30 years to 50 years
People
60
Run by
National and Kapodistrian University of Athens
See details and how to joinNCT07659028
No phaseTaking people
Long-term Adaptations of Skeletal Muscle After Hybrid Training
Where
Trikala
Age
30 years to 50 years
People
30
Run by
University of Thessaly
See details and how to joinNCT07341711
No phaseTaking people
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Where
Athens
Age
18 years and over
People
100
Run by
Attikon Hospital
See details and how to joinNCT07605572
No phaseTaking people
Evaluation of the Stress Response in Anesthesia Use Inhalation Anesthetic (Desflurane) Versus TIVA for Bariatric Surgery
Where
Athens
Age
18 years to 65 years
People
70
Run by
G.Gennimatas General Hospital
See details and how to joinNCT07568938
No phaseTaking people
Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy
Where
Athens
Age
18 years to 68 years
People
40
Run by
University Research Institute for the Study of Genetic & Malignant Disorders in Childhood
See details and how to joinNCT07278115
No phaseNot yet taking people in Greece
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
Where
Pátrai
Age
12 years to 25 years
People
840 worldwide
Run by
Aikaterini Karaivazoglou
See details and how to joinNCT07505459